Please assess the completion status of the following clinical trial:

Trial Title: Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. The hospitalized patient was administered Polyoxidonium, according to the instruction for medical usage in complex with Russian MoH guidance for treatment of COVID-19.~2. Verified coronavirus disease COVID-19, and at least one of the following:~   * severe disease: mechanical ventilation or oxygen supply required with blood oxygen saturation (SpO2) ≤ 94% on room air or tachypnea, respiratory rate ≥ 24 breaths per minute,~  * mild-moderate disease: SpO2 \> 94% on room air or respiratory rate \< 24 breaths per minute.~3. The patient signed an Informed Consent form for participation in this study.~4. The patient can understand all protocol requirements, perform the study procedures, and agree to all limitations specified in the protocol.~5. Male and female patients from 18 years of age.~6. Confirmed diagnosis of coronavirus disease (COVID-19): laboratory-confirmed Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR), or other commercial or public health assay in any specimen prior to inclusion.~Exclusion Criteria:~1. Pregnancy or breastfeeding.~2. Pathological condition that the study doctor considers significant enough to prevent enrolment of this patient.~3. Participation in any clinical study within 30 days before the Informed Consent form provided.~4. Hypersensitivity and/or intolerability to any ingredient of the investigational product.~5. Acute or chronic renal failure.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- Adult patients hospitalized with COVID-19 (Type: None): Patients eligible for enrollment into the study

Based on this trial design, predict the completion outcome and termination type (if applicable).